SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-287394
Filing Date
2018-09-28
Accepted
2018-09-28 16:02:06
Documents
4
Period of Report
2018-09-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d454251d8k.htm 8-K 17610
2 EX-99.1 d454251dex991.htm EX-99.1 83087
3 EX-99.2 d454251dex992.htm EX-99.2 53418
4 GRAPHIC g454251g18e90.jpg GRAPHIC 5271
  Complete submission text file 0001193125-18-287394.txt   162853
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 181094160
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10